AHA News: When an Untreated Infection Leads to Heart Valve Disease
MONDAY, Feb. 24, 2020 (American Heart Association News) -- Much as he tried, Gabriel Oluka could never keep up with other children.
As he got older, he experienced heaviness in his chest, frequent sore throats and occasional painful joints.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 24, 2020 Category: General Medicine Source Type: news
Cardiovalve Reaches 2 Milestones for its Tricuspid Valve Replacement System
Cardiovalve has a pair of milestones that could help catapult the company into the forefront of the tricuspid valve market. The Or Yehuda, Israel-based company received FDA approval for an early feasibility study of the transcatheter tricuspid valve replacement system and Breakthrough Device Designation for the technology.
The study’s primary endpoint is the safety and feasibility of the Cardiovalve technology and procedure in reducing tricuspid regurgitation, with evaluations at 30 days and periodically up to five years. The study will be conducted in collaboration with five leading US hospitals.
In a re...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Cardiovascular Source Type: news
Pioneering heart valve that grows inside the body could transform lives of children with defects
The prosthetic created by Boston Children's Hospital has been hailed as a huge step forward in medical care. In young lambs, it expanded with the growth of their own hearts. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2020 Category: Consumer Health News Source Type: news
Artificial Heart Valve Would Grow With Kids, Cutting Need for Repeat Surgeries
Title: Artificial Heart Valve Would Grow With Kids, Cutting Need for Repeat SurgeriesCategory: Health NewsCreated: 2/19/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 20, 2020 Category: Cardiology Source Type: news
Artificial Heart Valve Would Grow With Kids, Cutting Need for Repeat Surgeries
WEDNESDAY, Feb. 19, 2020 -- An expandable artificial heart valve could save children with congenital heart disease from repeated open heart surgeries as they grow up, researchers report.
Current artificial heart valves are fixed in size, meaning... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 19, 2020 Category: General Medicine Source Type: news
FDG-PET/CT points to cervical cancer patient outcomes
Several indicators on pretreatment FDG-PET/CT scans can help predict overall...Read more on AuntMinnie.comRelated Reading:
Biomarkers on PET, MRI show breast cancer risk
FDG-PET/CT within a year of heart valve surgery looks safe
FDG-PET/CT helps predict tuberculosis relapse
2 new PET tracers may best FDG in cancer imaging
FDG-PET/CT aids in melanoma treatment assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2020 Category: Radiology Source Type: news
Can 3D printing help optimize cardiac CT protocols?
Patient-specific 3D-printed coronary models have allowed clinicians to determine...Read more on AuntMinnie.comRelated Reading:
3 ways to advance 3D printing in radiology
AR, 3D printing make waves in cardiac care
3D printing helps unravel rare cardiac anomalies
3D printing technique improves heart valve sizing
3D printing gives pediatric heart surgery a boost (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2020 Category: Radiology Source Type: news
Aikawa, Shin Win Department of Medicine 2020 Innovation Evergreen Fund Award
Elena Aikawa, MD, PhD, director of the Heart Valve Translational Research Program in the Division of Cardiovascular Medicine, and Su Ryon Shin, PhD, of the Division of Engineering in Medicine, received the Brigham Department of Medicine ’s 2020 Innova (Source: BWH News)
Source: BWH News - February 7, 2020 Category: Hospital Management Source Type: news
Oregon man becomes first to receive minimally invasive heart valve repair
The tricuspid valve, on the right side of the heart between the top and bottom chambers, is very tricky to repair because of its complexity.
Until recently, the only option was open-heart surgery.
But an Oregon man recently became the first patient in a new clinical trial to have the valve repaired with a minimally invasive procedure.
Dennis Eggers, a 73-year-old from Sweet Home, Oregon, said he’s feeling “very well,” about two months after his mid-December valve repair at Oregon Health… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2020 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Abbott Wins Approval for CATALYST Trial for At-Risk Stroke Patients
This study is an extremely important step in assessing the Amplatzer Amulet as an effective non-prescription drug alternative for patients with AFib who are at an increased risk for ischemic stroke."
In an email sent to MD+DI, Abbott wrote, “We already have an Amulet IDE trial underway that is intended to support our submission for approval in the U.S. for Amplatzer Amulet. The newly announced CATALYST trial will support our submission for an expanded indication for Amulet as a safe and effective alternative to NOAC drugs for patients with atrial fibrillation and at risk of stroke.â€
Abbo...
Source: MDDI - February 3, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news
Abbott Has Big Win in TMVI Market
The transcatheter mitral valve implantation (TMVI) market is receiving a huge jolt through a new regulatory approval. Abbott Laboratories said it has obtained CE mark for the Tendyne System.
The Abbott Park, IL-based company’s device treats significant mitral regurgitation in patients requiring heart valve replacement who are not candidates for open-heart surgery or transcatheter mitral valve repair.
Tendyne is delivered through a small incision in the chest and up through the heart where it is implanted in a beating heart, replacing the person's native mitral valve. Abbott’s valve is fu...
Source: MDDI - January 30, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news
WPI researcher to probe link between cell death, calcification, and heart valve disease
(Worcester Polytechnic Institute) Worcester Polytechnic Institute researcher Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits that cause aortic valves to fail. The two-year project will involve laboratory experiments with cells grown in flat and three-dimensional shapes, and it will aim to discover ways to interrupt the process that leads to calcified nodules. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2020 Category: International Medicine & Public Health Source Type: news
Should We Worry About Bicuspid Aortic Valve?
Discussion
The aortic valve usually has 3 leaflets. In bicuspid aortic valve (BAV) there are 2 asymmetric leaflets with a fish-mouthed orifice between them which may not open fully. It occurs in about 0.5-2% of the population making it one of the most common congenital heart anomalies and the most common one in adults. Transmission is autosomal dominant yet males are more likely to have BAV, indicating potential reduced penetrance in females. “BAVs are different, however, in that the tissue pathology is not limited to the valves’ leaflets but extends from the left ventricular outflow tract to the ascending thor...
Source: PediatricEducation.org - January 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team
HANGZHOU, China, Jan. 20, 2020 -- (Healthcare Sales & Marketing Network) -- The leading transcatheter heart valve medical device player in China - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", stock code: 2500.HK), t... Devices, Interventional, Cardiology, Personnel Venus Medtech, transcatheter heart valve, VenusA-Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2020 Category: Pharmaceuticals Source Type: news
FDA clears patient-specific 3D-printed airway stent
The U.S. Food and Drug Administration (FDA) has cleared patient-specific 3D-printed...Read more on AuntMinnie.comRelated Reading:
3 ways to advance 3D printing in radiology
3D printing helps unravel rare cardiac anomalies
3D printing may improve safety of upper GI surgery
Wash. groups partner on 3D printing for heart disease
3D printing technique improves heart valve sizing (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2020 Category: Radiology Source Type: news
